Prometheus Laboratories partners with three regional health plans to offer precision-guided biologic testing to over five million members.

Prometheus Laboratories, a precision medicine leader for immune-mediated diseases, announced new health plan agreements with three large regional health plans. These agreements provide access to PredictrPK, precision-guided biologic testing, and other services for over five million members. PredictrPK helps optimize biologic treatment and reduce unnecessary patient suffering, flares, surgeries, and hospitalizations.